跳转到主要内容
主页 / 资源 / 会议 / Project Optimus: 如何与 FDA 接洽来推进您的项目

Project Optimus: 如何与 FDA 接洽来推进您的项目

Special Live Session - in person at DIA!

Join us for this SPECIAL SESSION taking place during DIA Global 2022. This is a cocktail reception with presentation and Q&A hosted by Julie Bullock, PharmD & ex FDA and Demetrius Carter at the Hyatt Regency McCormick Place.

Given the launch of Project Optimus, how do you best navigate the evolving regulatory landscape and determine the optimal way to engage with the agency?  Join this special event at DIA 2022 to address key questions that will help you to create a plan that’s tailored to your needs, whether you are at pre-IND stage or already in the clinical phases.

  • What is the actual ask from the FDA on Project Optimus?
  • When should you engage with the agency?
  • What should you talk about with the agency and how should you prepare?
  • What are best practices for your regulatory engagement and submission?

地点Prairie Room located on the 2nd floor of the Hyatt Conference Center

Space is limited
Register today for this in-person event at DIA 2022!

Thank you for registering for our special live session to be held on Tuesday, June 21st 5:30-7:30pm at Hyatt Regency McCormick Place (adjacent to the DIA Global conference at McCormick Place)

What to expect:

5:30 – 5:45 Refreshments

5:45 – 6:45 Presentation followed by Q&A

6:45 – 7:30 Refreshments

We will send email reminders ahead of the session.

We look forward to seeing you there!

演讲嘉宾
b1c97424 87d1 4534 b146 4e2bd0f1c115
Demetrius Carter
SVP, Regulatory Services
Demetrius Carter, RAC, is a clinical development executive with 20+ years of drug development experience in both the pharmaceutical and medical device industries. His experience includes roles at Glaxo SmithKline, Pfizer and JNJ before transitioning into the CRO industry. While at IQVIA, Demetrius held roles of increasing responsibilities in project management, clinical monitoring, and central laboratories. He also led global operations at Syneos Health for both the medical device and the oncology business units. Demetrius presently serves as the senior vice president, regulatory services at Certara where he oversees their regulatory writing, strategy, and operations functions. He has a Bachelor of Science in Biological Sciences from North Carolina State University and an MBA from Fairleigh Dickinson University. He also holds several certifications including Project Management Professional (PMP) from the Project Management Institute, Lean Six-Sigma Green Belt Certification from Villanova University, and the Regulatory Affairs Certification (RAC).
Julie Headshot big
Julie Bullock, PharmD
Senior Vice President, Global Head of Clinical Pharmacology & Translational Medicine

Julie 在 FDA 拥有 10 多年的药物开发经验。Dr Bullock's past appointments include Clinical Pharmacology Team Leader and Senior Clinical Pharmacology Reviewer (FDA). 她的监管经验主要集中在血液/肿瘤和凝血治疗领域。她对儿科开发、生物制剂的PK/PD分析和方法、肿瘤学剂量策略以及突破性疗法和加速审批的开发有独到的见解。Dr. Bullock 在其 10 年的 FDA 职业生涯中,为超过 14 项新分子实体的批准做出了贡献。

沪ICP备2022021526号

Powered by Translations.com GlobalLink OneLink Software